ARCHIVES

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

This article is from The Cancer Letter archive.

Vol. 33 No. 43 | November 23, 2007

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

John Niederhuber Named Acting NCI Director.

June 2, 2006

Consensus Conference On Receptors Planned

June 22, 1979

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014